Actively Recruiting
Ultrasound Biomicroscopy Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma
Led by Minia University Hospital · Updated on 2026-03-06
30
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on primary open-angle glaucoma, a chronic eye condition that often needs surgery when medications are not enough. It aims to study detailed ultrasound images of the eye's front part after a combined surgical procedure called deep sclerectomy with trabeculotomy. The study seeks to understand the anatomical changes after surgery and how they relate to patient outcomes. Patients who have undergone the combined deep sclerectomy with trabeculotomy surgery are observed using ultrasound biomicroscopy (UBM), a non-invasive imaging technique. UBM is used to examine the intrascleral lake, filtering bleb, and other eye structures after surgery. The study collects clinical data such as eye pressure and the number of glaucoma medications needed, correlating these with the UBM findings to identify predictors of surgical success. Participants will be evaluated at 3 and 6 months after surgery with UBM imaging and clinical assessments including intraocular pressure measurements and medication tracking. The study monitors anatomical and functional outcomes to better understand the effects of this combined surgery. The total participation includes postoperative follow-up visits for detailed imaging and clinical evaluation to assess safety and effectiveness.
CONDITIONS
Brief Title
UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of primary open-angle glaucoma (POAG), including juvenile open-angle glaucoma (JOAG)
- Patients who underwent combined deep sclerectomy with trabeculotomy
- Clear media allowing adequate ultrasound biomicroscopy imaging
- Written informed consent obtained from the patient
You will not qualify if you...
- Secondary glaucomas such as neovascular, uveitic, traumatic, or angle-closure glaucoma
- Previous glaucoma filtering surgery in the studied eye
- Coexisting ocular pathology affecting ultrasound biomicroscopy assessment, including severe corneal opacity or scleral pathology
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants who underwent combined deep sclerectomy with trabeculotomy are observed postoperatively. Ultrasound biomicroscopy is used to evaluate anterior segment structures such as the intrascleral lake and filtering bleb morphology. Clinical parameters including intraocular pressure and number of antiglaucoma medications are recorded and correlated with imaging findings.
Visits at 3 and 6 months postoperatively
Trial Site Locations
Total: 1 location
1
Minia University Hospital
Minya, Minya Governorate, Egypt
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here